Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin.

MLA

Ho, Gwo Yaw, et al. “Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin.” Cancer Research, vol. 82, no. 23, Dec. 2022, pp. 4457–73. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-21-4012.

APA

Ho, G. Y., Kyran, E. L., Bedo, J., Wakefield, M. J., Ennis, D. P., Mirza, H. B., Vandenberg, C. J., Lieschke, E., Farrell, A., Hadla, A., Lim, R., Dall, G., Vince, J. E., Chua, N. K., Kondrashova, O., Upstill-Goddard, R., Bailey, U.-M., Dowson, S., Roxburgh, P., … Barker, H. E. (2022). Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin. Cancer Research, 82(23), 4457–4473. https://doi.org/10.1158/0008-5472.CAN-21-4012

Chicago

Ho, Gwo Yaw, Elizabeth L Kyran, Justin Bedo, Matthew J Wakefield, Darren P Ennis, Hasan B Mirza, Cassandra J Vandenberg, et al. 2022. “Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin.” Cancer Research 82 (23): 4457–73. doi:10.1158/0008-5472.CAN-21-4012.